299. 嚢胞性線維症 [臨床試験数:1,592,薬物数:1,539(DrugBank:255),標的遺伝子数:81,標的パスウェイ数:162

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04530383August 22, 202024/8/2020A Trial of Metformin for Improving CFTR Function in CFRDAn Open Label Phase 2 Trial of Metformin for Improving CFTR Function in CFRDCystic Fibrosis-related Diabetes;Cystic FibrosisDrug: Metformin HydrochlorideUniversity of Kansas Medical CenterNULLActive, not recruiting18 YearsN/AAll20Phase 2United States
2EUCTR2009-009875-37-NL11/03/200921/01/2009A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes - Insulin therapy and adjuvant metformin in CFRDA placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes - Insulin therapy and adjuvant metformin in CFRD Cystic fibrosis-related diabetes
MedDRA version: 9.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)
MedDRA version: 9.1Level: LLTClassification code 10011762Term: Cystic fibrosis
Trade Name: Metformine HCL 500 PCHStaf LongziektenNULLNot RecruitingFemale: yes
Male: yes
25Netherlands